All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| US88160RAC51 / Tesla Motors, Inc. Bond 1.25% Due 3/1/2021
|
|
|
|
|
|
|
|
| 864909AA4 / Sucampo Pharmaceuticals, Inc. Bond
|
|
|
|
|
|
|
|
| BDXA / Becton Dickinson & Co. 6.125% Preferred Series A
|
|
|
|
|
|
|
|
| US75972AAC71 / Renewable Energy Group, Inc. Bond
|
|
|
|
|
|
|
|
| US69366JAB70 / PTC Therapeutics, Inc. Bond
|
|
|
|
|
|
|
|
| US292554AF97 / Encore Capital Group, Inc. Bond
|
|
|
|
|
|
|
|
| US00767EAB83 / Aegerion Pharmaceuticals, Inc. 2.0% Bond due 2019-08-15
|
|
|
|
|
|
|
|
| 038923AA6 / Arbor Realty Trust Inc Bond
|
|
|
|
|
|
|
|
| US00163UAD81 / AMAG Pharmaceuticals, Inc. Bond
|
|
|
|
|
|
|
|
| VTI / Vanguard Index Funds - Vanguard Total Stock Market ETF
|
|
|
|
|
|
|
|
| BCACW / Brookline Capital Acquisition Corp - Warrants (01/09/2025)
|
|
|
|
|
|
|
|
| 165167CR6 / Chesapeake Energy Corp. Bond
|
|
|
|
|
|
|
|
| US29089QAB14 / Emergent Biosolutions, Inc. Bond
|
|
|
|
|
|
|
|
| 29266SAB2 / Endologix, Inc. Bond
|
|
|
|
|
|
|
|
| US393222AF12 / Green Plains Inc 4.125 01sep22 Bond
|
|
|
|
|
|
|
|
| 521050AD6 / Layne Christensen Co. Bond
|
|
|
|
|
|
|
|
| 449575AB5 / Igi Laboratories Inc Bond
|
|
|
|
|
|
|
|
| US87305RAD17 / TTM Technologies, Inc. Bond
|
|
|
|
|
|
|
|
| 03762UAA3 / Apollo Commercial Real Estate Finance, Inc. Bond
|
|
|
|
|
|
|
|
| INDU / Industrea Acquisition Corp.
|
|
|
|
|
|
|
|
| US74838JAA97 / QUIDEL Corp. 3.25% Bond Due 12/15/2020
|
|
|
|
|
|
|
|
| US595017AD62 / Microchip Technology Inc. 1.625% Convertible Bond due 2025-12-15
|
|
|
|
|
|
|
|
| US88160RAD35 / Tesla Motors, Inc. Bond 2.375% Due 3/15/2022
|
|
|
|
|
|
|
|
| 177376AD2 / Citrix Systems, Inc. 0.5% Convertible Bond due 2019-04-15
|
|
|
|
|
|
|
|
| US901109AD04 / Tutor Perini Corp. Bond
|
|
|
|
|
|
|
|
| US90187BAA98 / Two Harbors Investment Corp. Fixed Income
|
|
|
|
|
|
|
|
| US750469AA69 / Radius Health, Inc. Bond
|
|
|
|
|
|
|
|
| US22943FAF71 / Ctrip.com International, Ltd. Bond 1.000% 7/0
|
|
|
|
|
|
|
|
| US143905AM99 / Carriage Services, Inc. Bond
|
|
|
|
|
|
|
|
| US82823LAC00 / Silver Standard Resources, Inc. Bond
|
|
|
|
|
|
|
|
| SAEXW / SAExploration Holdings, Inc.
|
|
|
|
|
|
|
|
| NH / NantHealth Inc
|
|
|
|
|
|
|
|
| AAPL / Apple Inc.
|
|
|
|
|
|
|
|
| US50187TAB26 / LGI Homes, Inc. Bond
|
|
|
|
|
|
|
|
| 34985B103 / Forum Merger Corporation
|
|
|
|
|
|
|
|
| US83416TAC45 / SolarCity Corp 1.625% Bond due 2019-11-01
|
|
|
|
|
|
|
|
| MMDM / Modern Media Acquisition Corp.
|
|
|
|
|
|
|
|
| US292554AH53 / Encore Capital Group, Inc. Bond
|
|
|
|
|
|
|
|
| 84763AAB4 / Spectrum Pharmaceuticals, Inc. 2.75% Bond Due 12/15/2018
|
|
|
|
|
|
|
|
| 493723AA8 / KEYW Holdings Corp 2.5% Bond due 2019-07-15
|
|
|
|
|
|
|
|
| US95790DAA37 / Western Asset Mtg Cap Corp Bond
|
|
|
|
|
|
|
|
| 369300AL2 / General Cable Corp. Bond
|
|
|
|
|
|
|
|
| US249908AA20 / DepoMed, Inc. 2.5% Bond Due 9/1/2021
|
|
|
|
|
|
|
|
| US88339KAA07 / Theravance Biopharma, Inc. Bond
|
|
|
|
|
|
|
|
| AVCT / American Virtual Cloud Technologies Inc
|
|
|
|
|
|
|
|
| US69329YAG98 / PDL BioPharma, Inc. Bond 2.75% Due 12/1/2021
|
|
|
|
|
|
|
|
| US00484MAA45 / Acorda Therapeutics, Inc. Bond 1.750% 6/1
|
|
|
|
|
|
|
|
